204 related articles for article (PubMed ID: 1379057)
1. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
van der Schouw YT; Verbeek AL; Wobbes T; Segers MF; Thomas CM
Br J Cancer; 1992 Jul; 66(1):148-54. PubMed ID: 1379057
[TBL] [Abstract][Full Text] [Related]
2. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Carpelan-Holmström MA; Haglund CH; Roberts PJ
Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
[TBL] [Abstract][Full Text] [Related]
3. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
4. Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.
Lindmark G; Kressner U; Bergström R; Glimelius B
Anticancer Res; 1996; 16(2):895-8. PubMed ID: 8687147
[TBL] [Abstract][Full Text] [Related]
5. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
[TBL] [Abstract][Full Text] [Related]
6. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
7. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma.
Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M
Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease.
Lindhorst E
Tumour Biol; 2000; 21(2):116-22. PubMed ID: 10686541
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
von Kleist S
Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
12. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
Arnaud JP; Koehl C; Adloff M
Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and prognostic value of CEA and GICA in colo-rectal tumors. A caseload contribution].
Lasagna B; Balbo G; De Paolis P; Sacchetti M
Minerva Med; 1990 Nov; 81(11):769-71. PubMed ID: 2255411
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
[TBL] [Abstract][Full Text] [Related]
17. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
Wu J; Yu H; Shao Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
20. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
Haglund C; Lundin J; Kuusela P; Roberts PJ
Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]